Bluesky Facebook Reddit Email

CRF announces TCT 2024 late-breaking clinical trials and science

08.27.24 | Cardiovascular Research Foundation

SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

NEW YORK – August 27, 2024 – The Cardiovascular Research Foundation ® (CRF ® ) is pleased to announce the late-breaking clinical trials and science to be featured at TCT ® 2024. As the annual scientific symposium of CRF ® and the world’s premier educational meeting specializing in interventional cardiovascular medicine, TCT ® 2024 will be held October 27-30 in Washington, D.C. at the Walter E. Washington Convention Center.

For over three decades, TCT ® has been at the forefront of innovation, education, and collaboration in interventional cardiology, with a steadfast commitment to improving the survival and quality of life for patients suffering from heart and vascular disease. Every year, TCT ® features groundbreaking research that directly impacts patient care and how physicians treat heart disease.

In the rapidly evolving field of medicine, late-breaking trials are highly anticipated and offer clinicians the opportunity to learn about new interventions, drugs, techniques, and strategies that could potentially improve patient outcomes. The 25 studies selected for presentation at TCT ® examine the safety and effectiveness of minimally invasive techniques, pharmaceuticals, technologies, and devices that demonstrate potential to treat or prevent cardiovascular disease. Late-breaking trials will be presented during the main sessions and highlighted during press conferences scheduled for Monday, October 28, Tuesday, October 29, and Wednesday, October 30.

Monday, October 28, 2024

Tuesday, October 29, 2024

Wednesday, October 30, 2024

Media are invited to attend TCT ® and can apply for media credentials at: https://tct2024.crfconferences.com/press-registration .

Receive updates on X at https://x.com/TCTConference and https://x.com/crfheart .

About CRF ® and TCT ®

The Cardiovascular Research Foundation ® (CRF ® ) is a global leader in interventional cardiovascular medicine, driving innovation, spearheading groundbreaking research, and transforming education in the field. Through its relentless pursuit of excellence, CRF ® not only accelerates medical breakthroughs but also equips healthcare professionals with the tools and knowledge necessary to enhance survival rates and elevate the quality of life for millions worldwide. CRF’s centers of excellence include the CRF Skirball Center for Innovation, CRF Clinical Trials Center, CRF Center for Education, CRF Digital, TCTMD, and Structural Heart: The Journal of the Heart Team .

Transcatheter Cardiovascular Therapeutics ® (TCT ® ) is the annual scientific symposium of CRF ® and the world’s premier educational meeting specializing in interventional cardiovascular medicine. Anchored in a legacy spanning over three decades, TCT ® is a world-class educational experience featuring disruptive innovation, scientific breakthroughs, expert-led tutorials, hands-on training, and ample opportunities for networking and collaboration.

For more information, visit www.crf.org and www.tctconference.com .

###

Keywords

Contact Information

Judy Romero
Cardiovascular Research Foundation
jromero@crf.org

Source

How to Cite This Article

APA:
Cardiovascular Research Foundation. (2024, August 27). CRF announces TCT 2024 late-breaking clinical trials and science. Brightsurf News. https://www.brightsurf.com/news/8Y4DP0OL/crf-announces-tct-2024-late-breaking-clinical-trials-and-science.html
MLA:
"CRF announces TCT 2024 late-breaking clinical trials and science." Brightsurf News, Aug. 27 2024, https://www.brightsurf.com/news/8Y4DP0OL/crf-announces-tct-2024-late-breaking-clinical-trials-and-science.html.